Hjem › Amyloidose › South Carolina
Amyloidose kliniske forsøg i South Carolina
4 studier for Amyloidose søger deltagere på steder i South Carolina.
Byer i South Carolina
Officiel studietekst (engelsk)
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
- Research Site, Greenville
RekruttererObservationsstudie
Alder 18 til 130 · Alle køn · Opdateret 23. sep. 2026 · NCT06465810TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Clinical Trial Site, Charleston
RekruttererFase 3
Alder 18 til 85 · Alle køn · Opdateret 16. sep. 2026 · NCT07052903Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Medical University of South Carolina (MUSC), Charleston
- Prisma Health Cancer Institute, Greenville
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 4. aug. 2026 · NCT06563895MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
- Medical University of South Carolina, Charleston
RekruttererFase 3
Alder 18 til 90 · Alle køn · Opdateret 27. mar. 2026 · NCT06128629Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.